Form 144 filed for UZE: 35,724 shares ($2.74M) via Morgan Stanley on NYSE
Rhea-AI Filing Summary
United States Cellular (symbol provided as UZE in metadata) filed a Form 144 disclosing a proposed sale of 35,724 common shares with an aggregate market value of $2,740,084.39. The sale is listed with Morgan Stanley Smith Barney LLC, Executive Financial Services and is scheduled on the NYSE for 08/12/2025. The filing shows the shares to be sold were mainly issued to the insider through restricted stock vesting under a registered plan on 04/05/2024 (34,055 shares) and 01/04/2024 (923 and 746 shares), with payment described as Services Rendered. The filer reports Nothing to Report for securities sold in the past three months and includes the standard representation that no undisclosed material adverse information is known.
Positive
- Transparent disclosure of proposed sale including broker, exchange, share count, and aggregate market value
- Securities originate from restricted stock vesting under a registered plan, indicating compensation-related disposition rather than market-driven sale
Negative
- None.
Insights
TL;DR: Small issuer insider sale filed under Rule 144; transaction appears routine and disclosed through a major broker.
The filing documents a proposed sale of 35,724 common shares valued at approximately $2.74 million, executed through Morgan Stanley Smith Barney on the NYSE. Shares originated from restricted stock vesting as compensation, which is typical for insider dispositions once transfer restrictions lapse. No prior disposals in the past three months are reported, reducing concerns about rapid insider unloading. Given disclosed source and broker handling, this appears to be a routine, compliance-focused disclosure rather than a material corporate development.
TL;DR: The Form 144 provides transparent disclosure of compensation-related share vesting and an intended sale; governance procedures appear followed.
The filing identifies the shares as coming from restricted stock vesting under a registered plan and documents the representative certification regarding undisclosed material information. Use of a national broker and explicit listing of shares outstanding and aggregate market value align with required transparency. Absence of recent disposals and the inclusion of standard signature/representation language suggest adherence to regulatory and governance expectations for insider trading disclosures.